Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

A girl with skin rashes and low zinc levels improved with zinc supplements and had new gene mutations linked to her condition.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

A new compound shows promise as a topical treatment for hair loss.

A rare EGFR mutation in newborns leads to severe health issues and early death.

The man's scalp condition improved significantly with daily use of 0.1% mometasone furoate cream.

Long-term etretinate use may cause delayed wound healing and extra tissue growth after injury.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Combining eflornithine cream with laser therapy effectively reduces unwanted facial hair in women.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Standard treatment for congenital erythropoietic porphyria was ineffective over five years.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Deuruxolitinib is approved to treat severe alopecia areata in adults.